We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

7 hedge funds and large institutions have $533K invested in China Pharma Holdings in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more capital invested

Capital invested by funds: $109K → $533K (+$424K)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

17% more funds holding

Funds holding: 6 → 7 (+1)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$6.28K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.33K
3
PCM
Parsons Capital Management
Rhode Island
+$2.56K
4
UBS Group
UBS Group
Switzerland
+$2.05K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$21K
2
VKH
Virtu KCG Holdings
New York
-$9K
3
Goldman Sachs
Goldman Sachs
New York
-$128

CPHI Hedge Fund Activity: Q3 2016 in Review

7 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2016, worth a combined $533K — up 389% from $109K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPHI positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $6.28K. The largest seller was Citadel Advisors, exiting entirely with an estimated $21K sold.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q3 2016, up from 6 in Q2 2016.
  • Funds reported $533K of China Pharma Holdings stock for Q3 2016, up 389% quarter-over-quarter.
  • 3 funds opened new China Pharma Holdings positions in Q3 2016 and 2 closed out, a net change of +1 holder.
  • The largest China Pharma Holdings buyer in Q3 2016 was Renaissance Technologies, an estimated $6.28K added.
  • The largest China Pharma Holdings seller in Q3 2016 was Citadel Advisors, an estimated $21K sold.

Based on aggregated 13F filings for Q3 2016.